You have read all your free articles, to continue reading subscribe to read the rest of this content.
Moberg Pharma's head of US operations, Steve Cagle, will resign by the end of January 2015. Steve Cagle has been part of the management team at Moberg Pharma since November 2012. "I am proud of the achievements during the last two years. We have almost doubled the net sales in…
The company announces that Andrew Parker will leave his position as Executive Vice President and Chief Scientific Officer. Andrew Parker has accepted a top executive leadership position in a non-competing biotechnology company outside Denmark. “I have thoroughly enjoyed my time at Zealand PhAlready a subscriber Login You have read all…
Valur Ragnarsson has been appointed as Chairman of the Board by Coripharma’s Board of Directors. Valur is a pharmaceutical executive with a solid track record spanning over 30 years, driving financial results and sustainable growth in the global generic pharmaceutical industry, describes the coAlready a subscriber Login You have read…
Cellavision's CEO Yvonne Mårtensson is leaving after 16 years at the company. Yvonne Mårtensson remains CEO until a successor is appointed or until 31 December 2014 at the latest. "I have had the privilege of being part of this exciting journey that started sixteen years ago. Together with Already a subscriber…
